COVID-19 and Obesity: Overlapping of Two Pandemics-Reference-Cited by-同舟云学术

COVID-19 and Obesity: Overlapping of Two Pandemics

Published:2021 Issue:6 Volume:14 Page:579-585
ISSN:1662-4025
Container-title:Obesity Facts
language:en
Short-container-title:Obes Facts

Author:

Gammone Maria Alessandra,D’Orazio Nicolantonio

Abstract

Background: The coronavirus disease 2019 (COVID-19) pandemic has recently led to worldwide research efforts to identify subjects at greater risk of developing more severe illness: overall obesity displayed a strong correlation with critical illness and major severity of COVID-19 manifestations. Summary: Obesity and metabolic disorders are closely linked to chronic systemic inflammation. The adipose tissue constitutes a source of cytokines, which configure a low-grade inflammation and a hypercoagulation status; in addition, diagnosis and care of obese patients are often complicated by excess weight and ventilation difficulties. Key Messages: This review aims to examine the intersection between obesity and adverse outcomes of COVID-19, in order to investigate its preventive and/or therapeutic potential in the management of obesity-related COVID-19 complications.

Publisher

S. Karger AG

Subject

Physiology (medical),Health(social science)

Reference33 articles.

1. Sanchis-Gomar F, Lavie CJ, Mehra MR, Henry BM, Lippi G. Obesity and outcomes in COVID-19: when an epidemic and pandemic collide. Mayo Clin Proc. 2020;95:1445–53.

2. Gkogkou E, Barnasas G, Vougas K, Trougakos IP. Expression profiling meta-analysis of ACE2 and TMPRSS2, the putative anti-inflammatory receptor and priming protease of SARS-CoV-2 in human cells, and identification of putative modulators. Redox Biol. 2020 Sep;36:101615.

3. Goossens GH, Dicker D, Farpour-Lambert NJ, Frühbeck G, Mullerova D, Woodward E, et al. Obesity and COVID-19: a perspective from the European Association for the study of obesity on immunological perturbations, therapeutic challenges, and opportunities in obesity. Obes Facts. 2020;13(4):439–52.

4. Francisco V, Ruiz-Fernández C, Pino J, Mera A, González-Gay MA, Gómez R, et al. Adipokines: linking metabolic syndrome, the immune system, and arthritic diseases. Biochem Pharmacol. 2019;165:196–206.

5. Landecho MF, Tuero C, Valentí V, Bilbao I, de la Higuera M, Frühbeck G. Relevance of leptin and other adipokines in obesity-associated cardiovascular risk. Nutrients. 2019;11(11):2664.

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of obesity on hospitalized patients with COVID-19 in southern Portugal;Obesity Medicine;2023-12

2. COVID-19 et obésité : quel rôle du tissu adipeux ?;Nutrition Clinique et Métabolisme;2023-12

3. Analysis of factors affecting enoxaparin effectiveness on coagulation, inflammation, and clinical outcomes in patients with COVID-19;Journal of Pharmacy & Pharmacognosy Research;2023-11-01

4. Adenovirus 36 seropositivity influences the expression of anti-adipogenic lncRNAs GAS5 and MEG3 in adipose tissue obtained from subjects with obesity;2023-10-31

5. Omega-3 Fatty Acids and COVID-19: Prevention or Adjuvant Therapy?;Current Research in Nutrition and Food Science Journal;2023-08-31